Brief: Nextcell Pharma Q2 Operating Loss Widens To SEK 8.1 Mln
29/04/2021 07:41
April 29 (Reuters) - NextCell Pharma AB NXTCL.ST :
* NEXTCELL PHARMA PUBLISHES INTERIM REPORT 2 2020/2021
* Q2 OPERATING INCOME AMOUNTED TO SEK 1 007 846 (1 364 645).
* Q2 OPERATING RESULT AMOUNTED TO SEK -8 148 299 (-4 228
449).
Source text for Eikon: ID:nWkr2MKL62
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln